144 related articles for article (PubMed ID: 10529738)
1. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra.
Boerrigter ME
Environ Mol Mutagen; 1999; 34(2-3):140-7. PubMed ID: 10529738
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of benzo(a)pyrene-induced gene mutations in male germ cells.
Verhofstad N; van Oostrom CT; Zwart E; Maas LM; van Benthem J; van Schooten FJ; van Steeg H; Godschalk RW
Toxicol Sci; 2011 Jan; 119(1):218-23. PubMed ID: 20961952
[TBL] [Abstract][Full Text] [Related]
3. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.
Ross JA; Nelson GB; Wilson KH; Rabinowitz JR; Galati A; Stoner GD; Nesnow S; Mass MJ
Cancer Res; 1995 Mar; 55(5):1039-44. PubMed ID: 7866986
[TBL] [Abstract][Full Text] [Related]
4. Mutant frequencies and spectra depend on growth state and passage number in cells cultured from transgenic lacZ-plasmid reporter mice.
Busuttil RA; Rubio M; Dollé ME; Campisi J; Vijg J
DNA Repair (Amst); 2006 Jan; 5(1):52-60. PubMed ID: 16126462
[TBL] [Abstract][Full Text] [Related]
5. Formation and persistence of novel benzo(a)pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA.
Ross J; Nelson G; Kligerman A; Erexson G; Bryant M; Earley K; Gupta R; Nesnow S
Cancer Res; 1990 Aug; 50(16):5088-94. PubMed ID: 2199033
[TBL] [Abstract][Full Text] [Related]
6. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
[TBL] [Abstract][Full Text] [Related]
7. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
8. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the mutagenicity of benzo(a)pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation.
Besaratinia A; Pfeifer GP
Cancer Res; 2003 Dec; 63(24):8708-16. PubMed ID: 14695185
[TBL] [Abstract][Full Text] [Related]
10. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
11. DNA adduct kinetics in reproductive tissues of DNA repair proficient and deficient male mice after oral exposure to benzo(a)pyrene.
Verhofstad N; van Oostrom CT; van Benthem J; van Schooten FJ; van Steeg H; Godschalk RW
Environ Mol Mutagen; 2010 Mar; 51(2):123-9. PubMed ID: 19634154
[TBL] [Abstract][Full Text] [Related]
12. Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model.
Louro H; Silva MJ; Boavida MG
Environ Mol Mutagen; 2002; 40(4):283-91. PubMed ID: 12489119
[TBL] [Abstract][Full Text] [Related]
13. Background mutations and polymorphisms in lacZ-plasmid transgenic mice.
Dollé ME; Snyder WK; van Orsouw NJ; Vijg J
Environ Mol Mutagen; 1999; 34(2-3):112-20. PubMed ID: 10529734
[TBL] [Abstract][Full Text] [Related]
14. Sources of variability in mutant frequency determinations in different organs of lacZ plasmid-based transgenic mice: experimental features and statistical analysis.
Boerrigter ME; Vijg J
Environ Mol Mutagen; 1997; 29(3):221-9. PubMed ID: 9142164
[TBL] [Abstract][Full Text] [Related]
15. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.
de Vries A; Dollé ME; Broekhof JL; Muller JJ; Kroese ED; van Kreijl CF; Capel PJ; Vijg J; van Steeg H
Carcinogenesis; 1997 Dec; 18(12):2327-32. PubMed ID: 9450477
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.
Boerrigter ME
Environ Mol Mutagen; 1998; 32(2):148-54. PubMed ID: 9776177
[TBL] [Abstract][Full Text] [Related]
17. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
Beland FA
Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
[TBL] [Abstract][Full Text] [Related]
18. DNA adducts, mutant frequencies, and mutation spectra in various organs of lambda lacZ mice exposed to ethylating agents.
Mientjes EJ; Luiten-Schuite A; van der Wolf E; Borsboom Y; Bergmans A; Berends F; Lohman PH; Baan RA; van Delft JH
Environ Mol Mutagen; 1998; 31(1):18-31. PubMed ID: 9464312
[TBL] [Abstract][Full Text] [Related]
19. Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons.
Godschalk RW; Moonen EJ; Schilderman PA; Broekmans WM; Kleinjans JC; Van Schooten FJ
Carcinogenesis; 2000 Jan; 21(1):87-92. PubMed ID: 10607738
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis studies with four stereoisomeric N2-dG benzo[a]pyrene adducts in the identical 5'-CGC sequence used in NMR studies: G->T mutations dominate in each case.
Seo KY; Nagalingam A; Tiffany M; Loechler EL
Mutagenesis; 2005 Nov; 20(6):441-8. PubMed ID: 16311255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
